Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

weight control

Stephanie Fulton, a CRCHUM researcher and professor at Université de Montréal, with David Lau, a doctoral student in Fulton’s laboratory

Brain Enzyme Discovery Opens New Path to Obesity Treatment

Stanford engineers have developed an injectable hydrogel depot technology that enables GLP-1 drugs to be administered once every four months, compared to repeated daily injections.

New drug delivery system could reduce daily diabetes shots to just three a year

Substack subscription form sign up

Comments

  • Marco Messina on More Than a Third of Americans Have Lost Relationships Over Politics
  • Anon on Why Fructose Behaves Less Like a Calorie and More Like a Hormone
  • Mark Mellinger on Living Plastic Can Self-Destruct on Command
  • Marie Feret on The Silent Frequency That Makes Old Buildings Feel Haunted
  • Dax on The Silent Frequency That Makes Old Buildings Feel Haunted
© 2026 ScienceBlog.com | Follow our RSS / XML feed